On Thursday, XL Group plc (NYSE:XL)’s shares declined -0.11% to $37.73.
To assist businesses recover from the financial repercussions of corporate crime, XL Catlin’s Global Crime business has introduced a comprehensive new commercial crime insurance policy in the US.
XL Catlin’s new Crime insurance policy comprises, but is not limited to, protection against:
- Employee Theftproviding coverage for loss of or damage to money, securities and other property resulting directly from theft committed by an employee.
- Forgery or Alterationresulting in losses arising directly from forgery or alteration of checks, drafts, promissory notes or similar instruments.
- Theft of Money and Securitieson and off premises, resulting in losses of money and securities inside the insured’s premises or a financial institution’s premises
- Robbery or Safe Burglaryfor loss or damage to property other than money or securities
- Computer and Funds Transfer Fraudcovering losses that result directly from fraudulent entry or change in electronic data or computer programs
- Money Orders and Counterfeit Moneyto cover loss resulting directly from a company having accepted these in good faith in exchange for merchandise, money or services.
To tailor a company’s policy to address a specific industry or risks unique to the business, a variety of endorsements are also accessible to address identity fraud, telephone toll fraud, safe depository, and client’s property, among others.
XL GROUP Public Limited Company, an insurance and reinsurance company, provides property, casualty, and specialty products to industrial, commercial, and professional firms; and insurance companies and other enterprises worldwide. The company operates in two segments: Insurance and Reinsurance.
Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN)’s shares gained 0.12% to $167.99.
Alexion Pharmaceuticals, Inc. (ALXN) declared that researchers will present new data on the long-term efficacy and tolerability of Strensiq™ (asfotase alfa) in children with hypophosphatasia (HPP) who were treated for up to five years, in addition to new data comparing the functional mobility of children with HPP treated with Strensiq contrast to untreated historical control patients. Researchers will also present new data on the dosing for Strensiq in patients with HPP and the use of the Radiographic Global Impression of Change (RGI-C) scale for assessing skeletal manifestations of HPP in infants and children, together with a case literature review of HPP manifestations in adults with pediatric-onset HPP. The data will be presented at the 2015 American Society for Bone and Mineral Research (ASBMR) Annual Meeting being held October 9-12, 2015, in Seattle.
HPP is a genetic and progressive metabolic disease in which patients experience devastating effects on multiple systems of the body, leading to debilitating or life-threatening complications. It is an ultra-rare disease, which is defined as a disease that affects fewer than 20 patients per one million in the general population.1 HPP is characterized by defective bone mineralization that can lead to deformity of bones and other skeletal abnormalities, in addition to systemic complications such as profound muscle weakness, seizures, pain, and respiratory failure leading to premature death in infants.2-6
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease.
At the end of Thursday’s trade, Koninklijke Philips NV (ADR) (NYSE:PHG)‘s shares dipped -1.18% to $25.15.
Royal Philips (PHG) and Netherlands -based Radboud university medical center (Radboudumc) recently introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
The system, comprising of a mobile patient app and online community, is the first to collect and connect data from electronic medical records, multiple personal health devices – counting wireless glucose meters and activity monitors – and patient self-stated data. Via a smartphone or tablet, the app gives patients continuous access to important parameters such as blood glucose levels, insulin use, and nutrition and provides coaching guidance* at home and on the go. The secure online community is where enrolled patients and healthcare professionals can interact via private messaging or shared posts within a healthcare organization’s clinical guidelines. In this way, patients can get feedback from their care team using the combined data and can easily share experiences with fellow patients, clinicians and caregivers.
Koninklijke Philips N.V. engages in healthcare, consumer lifestyle, and lighting businesses worldwide. It provides various integrated clinical solutions, counting radiation oncology and portfolio administration; computed tomography, magnetic resonance imaging, and molecular imaging products; digital X-ray and mammography products; interventional X-ray products in cardiology, radiology, surgery, and other areas; and ultrasound products.
Voya Financial Inc (NYSE:VOYA), ended its Thursday’s trading session with -3.02% loss, and closed at $41.68.
Voya Financial, Inc. (VOYA), declared recently that it has published the company’s most recent Corporate Responsibility Annual Report, which details the organization’s corporate responsibility (CR) approach in four key areas: community investment, environmental sustainability, multicultural affairs and business practices and principles.
The report, entitled “In Their Own Words,” features thoughts and insights from Voya’s board of directors, senior administration and a cross-section of employees from across the company. Organized according to the four “pillars” that serve as the framework for Voya’s CR strategy, the report highlights comprise the following:
Community Investment — through Voya Foundation grants, Voya aims to improve the quality of life in the communities where its employees and customers live and work. Voya Foundation’s giving areas comprise children’s education, financial literacy and disaster relief. This pillar also supports the company’s employee volunteerism and giving efforts, in addition to nonprofit board participation by senior administration.
- Voya’s CR Report highlights the company’s support of signature programs and partnerships such as the National Teacher of the Year, Voya Unsung Heroes, Junior Achievement and the Voya-Girls Inc. Investment Challenge.
- In 2014, Voya Financial held its inaugural National Day of Service (NDOS). The company-wide initiative encourages Voya employees to volunteer on one single day for a wide range of causes. This initiative engaged nearly half of the company’s 6,500 employees. Counting the efforts of NDOS, Voya Financial employees volunteered more than 39,500 hours serving community organizations over the course of the year.
Voya Financial, Inc. operates as a retirement, investment, and insurance company in the United States. The company has five segments: Retirement, Annuities, Investment Administration, Individual Life, and Employee Benefits. The Retirement segment offers tax-deferred employer-sponsored retirement savings plans and administrative services in corporate, education, healthcare, and government markets; and rollover individual retirement accounts and other retail financial products, in addition to financial advisory services to individual customers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
